Literature DB >> 21346352

Efflux pump overexpression in conjunction with alternation of outer membrane protein may induce Acinetobacter baumannii resistant to imipenem.

LiuLin Luo1, XiaoFei Jiang, Qiong Wu, LiMing Wei, JianHua Li, ChunMei Ying.   

Abstract

BACKGROUND: To investigate the role of outer membrane proteins in Acinetobacter baumannii resistant to imipenem, 2 strains were procured from the same patient.
METHODS: The imipenem-resistant strain was obtained following a period of imipenem treatment in vivo. The multilocus sequence typing and repetitive extragenic palindromic PCR results indicated that the imipenem-resistant strain originated from the sensitive one.
RESULTS: Isoelectric focusing detected no carbapenemases, with neither OXA carbapenemases nor metallo-β-lactamases found. Mass spectrophotometric analysis revealed that 3 outer membrane proteins were expressed differentially in the 2 strains: 2 downregulated proteins (OprD and CarO) and 1 upregulated the 34-kDa efflux pump protein in the resistant strain. A 32-fold decrease in the MIC for imipenem in the presence of Phe-Arg-β-naphthylamide in the same strain indicated a possible involvement of the efflux pump mechanism in its resistance, which was consistent with the findings that the mRNA expression of the 34-kDa efflux pump gene was almost fivefold upregulated in the imipenem-resistant strain compared with that in the imipenem-sensitive strain. Such a significant difference, however, was not found in the expression of AdeB and AdeJ between the 2 strains, and AdeE was not detected.
CONCLUSIONS: Our results suggested that downregulation of outer membrane proteins in conjunction with efflux pump overexpression might contribute to imipenem resistance induced in vivo in A. baumannii.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21346352     DOI: 10.1159/000323620

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  11 in total

1.  Loss of the OprD homologue protein in Acinetobacter baumannii: impact on carbapenem susceptibility.

Authors:  Younes Smani; Jerónimo Pachón
Journal:  Antimicrob Agents Chemother       Date:  2013-01       Impact factor: 5.191

2.  The Acinetobacter Outer Membrane Contains Multiple Specific Channels for Carbapenem β-Lactams as Revealed by Kinetic Characterization Analyses of Imipenem Permeation into Acinetobacter baylyi Cells.

Authors:  Jorgelina Morán-Barrio; María M Cameranesi; Verónica Relling; Adriana S Limansky; Luciano Brambilla; Alejandro M Viale
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

3.  Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbam.

Authors:  Craig J McPherson; Lisa M Aschenbrenner; Brian M Lacey; Kelly C Fahnoe; Margaret M Lemmon; Steven M Finegan; Baswanth Tadakamalla; John P O'Donnell; John P Mueller; Andrew P Tomaras
Journal:  Antimicrob Agents Chemother       Date:  2012-10-01       Impact factor: 5.191

Review 4.  Targeting the Holy Triangle of Quorum Sensing, Biofilm Formation, and Antibiotic Resistance in Pathogenic Bacteria.

Authors:  Ronit Vogt Sionov; Doron Steinberg
Journal:  Microorganisms       Date:  2022-06-16

5.  Early insights into the interactions of different β-lactam antibiotics and β-lactamase inhibitors against soluble forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3.

Authors:  Krisztina M Papp-Wallace; Baui Senkfor; Julian Gatta; Weirui Chai; Magdalena A Taracila; Veerabahu Shanmugasundaram; Seungil Han; Richard P Zaniewski; Brian M Lacey; Andrew P Tomaras; Marion J Skalweit; Michael E Harris; Louis B Rice; John D Buynak; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

6.  Adaptation-based resistance to siderophore-conjugated antibacterial agents by Pseudomonas aeruginosa.

Authors:  Andrew P Tomaras; Jared L Crandon; Craig J McPherson; Mary Anne Banevicius; Steven M Finegan; Rebecca L Irvine; Matthew F Brown; John P O'Donnell; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2013-06-17       Impact factor: 5.191

7.  Deciphering the function of the outer membrane protein OprD homologue of Acinetobacter baumannii.

Authors:  Manuella Catel-Ferreira; Rony Nehmé; Virginie Molle; Jesús Aranda; Emeline Bouffartigues; Sylvie Chevalier; Germán Bou; Thierry Jouenne; Emmanuelle Dé
Journal:  Antimicrob Agents Chemother       Date:  2012-05-07       Impact factor: 5.191

8.  Association of blaOXA-23 and bap with the persistence of Acinetobacter baumannii within a major healthcare system.

Authors:  Ting L Luo; Alexander H Rickard; Usha Srinivasan; Keith S Kaye; Betsy Foxman
Journal:  Front Microbiol       Date:  2015-03-12       Impact factor: 5.640

9.  Metabolomic profiling for the identification of potential biomarkers involved in a laboratory azole resistance in Candida albicans.

Authors:  Ling Li; ZeBin Liao; Yu Yang; Lei Lv; YingYing Cao; ZhenYu Zhu
Journal:  PLoS One       Date:  2018-02-02       Impact factor: 3.240

10.  Overproduction of efflux pumps caused reduced susceptibility to carbapenem under consecutive imipenem-selected stress in Acinetobacter baumannii.

Authors:  Yanpeng Zhang; Zhuocheng Li; Xiaolong He; Fanglin Ding; Weiqing Wu; Yong Luo; Bing Fan; Hong Cao
Journal:  Infect Drug Resist       Date:  2018-03-29       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.